Anti Rejection Drugs

What Are Anti Rejection Drugs? 

Anti-rejection medications — also called immunosuppressants — are essential lifelong therapies for transplant recipients to prevent the immune system from attacking a donor organ. They are also used for autoimmune conditions including rheumatoid arthritis, lupus, and inflammatory bowel disease. AmozonPill stocks 22 generic immunosuppressant medications covering calcineurin inhibitors, antiproliferatives, and corticosteroids — sourced from FDA-inspected manufacturers at up to 95% below brand-name prices. 

 Drug Classes Available 

  • Calcineurin Inhibitors: Tacrolimus (FK506), Cyclosporine — backbone of solid organ transplant immunosuppression. Inhibit T-lymphocyte activation, preventing graft rejection. Require regular blood level monitoring. 
  • Antiproliferative Agents: Mycophenolate Mofetil, Mycophenolic Acid, Azathioprine — inhibit lymphocyte proliferation by blocking purine synthesis. Used in triple immunosuppression regimens alongside calcineurin inhibitors. 
  • mTOR Inhibitors: Sirolimus (Rapamycin), Everolimus — block the mTOR pathway, inhibiting lymphocyte proliferation. Used as alternatives or adjuncts to calcineurin inhibitors, with renal-sparing properties. 
  • Corticosteroids: Prednisolone, Methylprednisolone — broad anti-inflammatory agents used for induction, maintenance, and treatment of acute rejection episodes in transplant patients. 

Why Buy Generic? 

  • Generic Tacrolimus from $35 vs $400+ per month for Prograf brand 
  • Generic Mycophenolate from $28 vs $250+ for CellCept brand 
  • Generic Cyclosporine from $42 vs $350+ for Neoral brand 
  • FDA-inspected, WHO-GMP-certified manufacturers 
  • Critical long-term savings for transplant patients on lifelong therapy 

How to Choose the Right Product 

Anti-rejection drug selection and dosing is determined exclusively by the transplant team. AmozonPill provides access to the same generic molecules at significantly lower cost for long-term maintenance therapy. Do not adjust doses, switch formulations, or stop immunosuppressants without specialist guidance — rejection episodes can lead to irreversible graft loss. 

Frequently Asked Questions

Why must Tacrolimus blood levels be monitored? 

Tacrolimus has a narrow therapeutic index — too low causes rejection, too high causes nephrotoxicity, neurotoxicity, and infection risk. Regular trough blood level monitoring every 1–3 months (more frequently post-transplant) is mandatory. 

Can generic Tacrolimus be substituted for brand Prograf? 

Generic Tacrolimus is bioequivalent to Prograf at the population level, but individual patients may show variability when switching. If switching, blood level monitoring should be increased and the change should always be made under transplant team supervision. 

What is the difference between Mycophenolate Mofetil and Mycophenolic Acid? 

Mycophenolate Mofetil (MMF) is a prodrug converted to Mycophenolic Acid (MPA) after absorption. Enteric-coated Mycophenolic Acid (Myfortic) delivers MPA directly, reducing upper GI side effects. Both have equivalent immunosuppressive efficacy. 

What infections are transplant patients at risk of on immunosuppressants? 

Immunosuppressants increase susceptibility to bacterial, viral (CMV, EBV, HSV), fungal (Candida, Aspergillus), and opportunistic (PCP, Toxoplasma) infections. Prophylactic antiviral and antifungal agents are routinely prescribed post-transplant. 

How long do patients take anti-rejection medicines? 

Lifelong. Stopping immunosuppression leads to rejection and graft loss regardless of how long the transplant has been functioning. Doses are typically tapered over years to a low maintenance level. 

Can immunosuppressants be used for autoimmune diseases? 

Yes. Azathioprine, Mycophenolate, Cyclosporine, and Tacrolimus are all used in autoimmune conditions including lupus nephritis, myasthenia gravis, inflammatory bowel disease, and severe psoriasis. 

Showing 1–12 of 29 results